Trial Profile
Clinical Trials Insight: 700009609
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2009
Price :
$35
*
At a glance
- Drugs Bremelanotide (Primary)
- Indications Female sexual dysfunction; Menopause
- Focus Therapeutic Use
- Sponsors Palatin Technologies; Pfizer